HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kengo Tanabe Selected Research

Neointima

12/2017Two-year vascular responses to drug-eluting stents with biodegradable polymer versus durable polymer: An optical coherence tomography sub-study of the NEXT.
1/2014Vascular response to drug-eluting stent with biodegradable vs. durable polymer. Optical coherence tomography substudy of the NEXT.
12/2003Usefulness of shear stress pattern in predicting neointima distribution in sirolimus-eluting stents in coronary arteries.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kengo Tanabe Research Topics

Disease

52Myocardial Infarction
03/2024 - 02/2003
42Thrombosis (Thrombus)
03/2024 - 08/2002
34Hemorrhage
10/2023 - 04/2009
20Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 02/2003
17Stroke (Strokes)
10/2023 - 07/2016
15Heart Failure
03/2024 - 04/2017
14Coronary Artery Disease (Coronary Atherosclerosis)
01/2024 - 09/2002
12Acute Coronary Syndrome
08/2023 - 06/2003
11Death (Near-Death Experience)
03/2024 - 01/2012
11Pathologic Constriction (Stenosis)
09/2019 - 09/2002
9ST Elevation Myocardial Infarction
01/2023 - 11/2004
8Aortic Valve Stenosis (Aortic Stenosis)
11/2023 - 07/2017
6Ischemic Stroke
06/2022 - 01/2018
5Atrial Fibrillation
05/2022 - 01/2018
5Hyperplasia
11/2016 - 08/2002
4Chronic Renal Insufficiency
01/2023 - 05/2018
4Non-ST Elevated Myocardial Infarction
10/2021 - 06/2017
4Unstable Angina
01/2021 - 06/2017
3Myocardial Ischemia (Ischemic Heart Diseases)
03/2024 - 09/2003
3Chest Pain (Chest Pains)
11/2023 - 08/2006
3Anemia
10/2021 - 11/2019
3Neointima
12/2017 - 12/2003
2Body Weight (Weight, Body)
08/2023 - 02/2021
2Rupture
05/2023 - 12/2018
2Hemorrhagic Stroke
11/2019 - 01/2019
2Lung Neoplasms (Lung Cancer)
01/2019 - 05/2018
2Hematoma
12/2018 - 04/2009
2Infarction (Infarctions)
09/2018 - 08/2006
2Atherosclerotic Plaque (Atheroma)
05/2018 - 10/2017
2Abdominal Aortic Aneurysm
04/2018 - 07/2017
2Diabetes Mellitus
04/2018 - 01/2013
2Heart Arrest (Cardiac Arrest)
01/2018 - 11/2004
2Cardiogenic Shock
01/2018 - 11/2004
1Malnutrition (Nutritional Deficiencies)
03/2024
1Frailty
03/2024
1Cachexia
03/2024
1Sarcopenia
03/2024
1Persistent Left Superior Vena Cava
02/2024
1Cardiac Sudden Death (Sudden Cardiac Arrest)
12/2023
1Congenital Heart Defects (Congenital Heart Defect)
11/2023
1Guillain-Barre Syndrome
11/2023
1Polyneuropathies (Polyneuropathy)
11/2023
1Infections
11/2023
1Bicuspid Aortic Valve Disease
02/2023
1Type 2 Diabetes Mellitus (MODY)
01/2023
1Myocarditis (Carditis)
05/2022
1Fever (Fevers)
05/2022

Drug/Important Bio-Agent (IBA)

17omega-Chloroacetophenone (Mace)IBA
10/2021 - 06/2003
17Sirolimus (Rapamycin)FDA Link
06/2008 - 08/2002
142'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
10/2023 - 01/2018
7EverolimusFDA Link
08/2023 - 01/2015
7Prasugrel HydrochlorideFDA Link
03/2023 - 12/2020
6MetalsIBA
01/2019 - 09/2002
5BESIBA
08/2023 - 07/2013
5Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
03/2023 - 01/2019
4Clopidogrel (Plavix)FDA Link
02/2023 - 01/2019
4AnticoagulantsIBA
05/2022 - 12/2020
4Creatine Kinase (Creatine Phosphokinase)IBA
09/2020 - 05/2004
3Glucose (Dextrose)FDA LinkGeneric
03/2024 - 05/2023
3SodiumIBA
03/2024 - 05/2023
3ChromiumIBA
01/2022 - 01/2019
3CobaltIBA
01/2022 - 01/2019
3TroponinIBA
01/2021 - 06/2017
3Indicators and Reagents (Reagents)IBA
09/2020 - 03/2018
3Tissue Plasminogen Activator (Alteplase)FDA Link
11/2019 - 01/2018
3StreptokinaseFDA Link
11/2019 - 01/2018
3CalciumIBA
05/2018 - 10/2017
2Brain Natriuretic Peptide (Natrecor)FDA Link
02/2024 - 09/2020
2dapagliflozinIBA
12/2023 - 05/2023
2PolymersIBA
08/2023 - 01/2004
2NitrogenIBA
10/2021 - 03/2018
2Urea (Carbamide)FDA LinkGeneric
10/2021 - 03/2018
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
05/2021 - 10/2017
2Paclitaxel (Taxol)FDA LinkGeneric
01/2004 - 02/2003
1GangliosidesIBA
11/2023
1Angiotensin Receptors (Angiotensin II Receptor)IBA
08/2023
1Neprilysin (Neutral Endopeptidase)IBA
08/2023
1Acetylglucosaminidase (NAGase)IBA
08/2023
1DiureticsIBA
08/2023
1pro-brain natriuretic peptide (1-76)IBA
08/2023
1SymportersIBA
05/2023
1AntithrombinsIBA
02/2023
1Troponin T (Troponin T1)IBA
02/2023
1Biomarkers (Surrogate Marker)IBA
01/2023
1finerenoneIBA
01/2023
12019-nCoV Vaccine mRNA-1273IBA
05/2022
1Messenger RNA (mRNA)IBA
05/2022
1COVID-19 VaccinesIBA
05/2022

Therapy/Procedure

70Stents
03/2024 - 08/2002
41Percutaneous Coronary Intervention
03/2024 - 11/2004
25Therapeutics
05/2023 - 01/2018
14Drug-Eluting Stents
08/2023 - 08/2002
11Transcatheter Aortic Valve Replacement
11/2023 - 07/2017
5Coronary Artery Bypass (Coronary Artery Bypass Surgery)
11/2018 - 02/2003
3Renal Dialysis (Hemodialysis)
05/2018 - 08/2009
2Secondary Prevention
10/2021 - 09/2020
2Patient Readmission
01/2021 - 01/2021
1Catheters
02/2024
1Wearable Electronic Devices
11/2023
1Prostheses and Implants (Prosthesis)
02/2023